Crossmark

Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From Spain

Crossref DOI link: https://doi.org/10.1016/j.ad.2025.104563

Published Print: 2026-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Silvestre-Salvador, J.F. https://orcid.org/0000-0002-8532-6338
Santos-Alarcón, S.

Mengual-Sendra, A.

Zaragoza-Ninet, V.

Ortega-García, M.P.

Rodriguez, M.

Monte-Boquet, E.

Ruiz de Apodaca, R.F.

Pérez Prior, N.

Miquel-Miquel, F.J.

Borras-Blasco, J.
Funding

Funding for this research was provided by:

Sanofi

Sanofi Aventis SA
License Information

Text and Data Mining valid from 2026-04-01

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2025-12-11
More Information

This article is maintained by: Elsevier

Article Title: Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From Spain

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2025.104563

Content Type: article

Copyright: © 2025 AEDV. Published by Elsevier España, S.L.U.